Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Head & Neck 1

Conditions

Papillomavirus Infections 2 Urinary Bladder Neoplasms 1 Mouth Diseases 1 Lymphoma 1 Kidney Neoplasms 1 Hematuria 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Anus Neoplasms 1

Interventions

Cyclophosphamide 62 Rituximab 52 fludarabine 34 Prednisone 34 Doxorubicin 29 Vincristine 26 Biopsy 26 Specimen Handling 22 Magnetic Resonance Spectroscopy 20 Bendamustine Hydrochloride 19 pembrolizumab 17 Lenalidomide 17 obinutuzumab 14 fludarabine phosphate 14 Etoposide 14 venetoclax 13 Tacrolimus 11 Mycophenolic Acid 10 Melphalan 10 Dexamethasone 10 zanubrutinib 9 ibrutinib 9 acalabrutinib 9 Radiotherapy 9 Gemcitabine 9 Cytarabine 9 Busulfan 9 Whole-Body Irradiation 8 Mesna 8 Filgrastim 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma × Cytological Techniques × 1 year × Clear all

NCT05010369 2025-06-26

DOLPHIN-VIVO

University of Exeter

Phase NA Terminated

Head & NeckLymphoid

Head and Neck Neoplasms, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡